[Federal Register Volume 65, Number 165 (Thursday, August 24, 2000)]
[Notices]
[Page 51595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-21659]



[[Page 51595]]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Protective Monoclonal 
Antibody Against Botulinum Neurotoxin Serotype F

AGENCY: U.S. Army Medical Research and Materiel Command, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent Application Serial Number 08/
504,969 entitled ``Protective Monoclonal Antibody Against Botulinum 
Neurotoxin Serotype F'', filed July 20, 1995. This patent has been 
assigned to the United States Government as represented by the 
Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The subject application invention relates to 
a monoclonal antibody protective against botulinum neurotoxin serotype 
F, and to methods of preparation and use thereof.

Gregory D. Showalter,
Army Federal Register Liaison Officer.
[FR Doc. 00-21659 Filed 8-23-00; 8:45 am]
BILLING CODE 3710-08-U